Conclusion
In a community practice, uncomplicated constipation should be approached in a stepwise manner. Although most patients may have their own methods to deal with acute problems, they occasionally need a one-time oral cathartic or large-volume enema in the beginning of treatment, to start with a “clean slate.” In these situations, prior to treatment, confirmation of constipation is usually easily accomplished by reviewing an abdominal x-ray.
Most patients’ symptoms of constipation can be treated with daily fiber supplements and behavior modification. Of the remaining patients, many respond to rectally administered glycerin suppositories, enemas, or the judicious use of an oral stimulant, such as magnesium or senna.
For those continuing with symptoms despite conservative management, the practitioner will have to decide whether to proceed with prescription therapy such as polyethylene glycol or Tegaserod, or refer the patient for physiologic-anatomic testing with marker studies and defecography.
In the near future, effective therapy for narcotic-induced constipation will likely be available. Until then, aggressive, nonspecific therapy accompanied by minimization or elimination of the offending substance is warranted.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
McMillan SC, Tittle M. A descriptive study of the management of pain and pain-related side effects in a cancer center and a hospice. Hosp J 1995;10:89–108.
Sandler RS, Drossman DA. Bowel habits in young adults not seeking health care. Dig Dis Sci 1987;32:841.
Huizinga JD, Daniel EE. Motor functions of the colon. In: Philips SF, Pemberton JH, Shorter RG, eds. The Large Intestine: Physiology, Pathophysiology, and Disease. New York: Raven Press, 1991:93–114.
Kellow JE, Borody TJ, Phillips SF, Tucker RL, Haddad AC. Human interdigestive motility: variations in patterns from esophagus to colon. Gastroenterology 1986;91(2):386–395.
Huizinga JD. Electrophysiology of human colon motility in health and disease. Clin Gastroenterol 1986;15(4):879–901.
Sonnenberg A, Koch TR. Physician visits in the United States for constipation: 1958-1986. Dig Dis Sci 1989;34:606.
Locke GR III, Pemberton JH, Phillips SF. AGA technical review on constipation. Gastroenterology 2000;19:1766–1768.
Eisenberg DM, Davis RB, Ettner SL, et al. Trends in alternative medicine use in the United States, 1990–1997: results of a follow-up national survey. JAMA 1998;280(18):1569–1575.
Vickers A, Zollman C. ABC of complementary medicine: herbal medicine. BMJ 1999;319(7216):1050–1053.
Smart HL, Mayberry JF, Atkinson M. Alternative medicine consultations and remedies in patients with the irritable bowel syndrome. Gut 1986;27(7):826–828.
Okada T. Über den metabolismus der Senna—Abführung. Tohoku J Exp Med 1940;38:33–41.
Fairbairn JW. Chemical structure, mode of action and therapeutical activity of anthraquinone glycosides. Pharm Weekbl 1965;100(51):1493–1499.
Lemli J. Senna—an old drug in modern research. Pharmacology 1988;36(suppl 1):3–6.
Franz G. The senna drug and its chemistry. Pharmacology 1993;47(suppl 1):2–6.
Leng-Peschlow E. Dual effect of orally administered sennosides on large intestine transit and fluid absorption in the rat. J Pharm Pharmacol 1986;38(8):606–610.
Beubler E, Kollar G. Stimulation of PGE2 synthesis and water and electrolyte secretion by senna anthraquinones is inhibited by indomethacin. J Pharm Pharmacol 1985;37(4):248–251.
Yamauchi K, Yagi T, Kuwano S. Suppression of the purgative action of rhein anthrone, the active metabolite of sennosides A and B, by calcium channel blockers, calmodulin antagonists and indomethacin. Pharmacology 1993;47(suppl 1):22–31.
Izzo AA, Mascolo N, Capasso F. Nitric oxide as a modulator of intestinal water and electrolyte transport. Dig Dis Sci 1998;43(8):1605–1620.
Benavides SH, Morgante PE, Monserrat AJ, Zarate J, Porta EA. The pigment of melanosis coli: a lectin histochemical study. Gastrointest Endosc 1997;46(2):131–138.
Nadal SR, Calore EE, Manzione CR, Puga FR, Perez NM. Effects of long-term administration of senna occidentalis seeds in the large bowel of rats. Pathol Res Pract 2003;199(11):733–737.
van Gorkom BA, Karrenbeld A, van Der Sluis T, Koudstaal J, de Vries EG, Kleibeuker JH. Influence of a highly purified senna extract on colonic epithelium. Digestion 2000;61(2):113–120.
Nusko G, Schneider B, Ernst H, Wittekind C, Hahn EG. Melanosis coli—a harmless pigmentation or a precancerous condition? Z Gastroenterol 1997;35(5):313–318.
Joo JS, Ehrenpreis ED, Gonzalez L, et al. Alterations in colonic anatomy induced by chronic stimulant laxatives: the cathartic colon revisited. J Clin Gastroenterol 1998;26(4):283–286.
Campbell WL. Cathartic colon. Reversibility of roentgen changes. Dis Colon Rectum 1983;26(7):445–448.
Davis GR, Santa Ana CA, Morawski SG, Fordtran JS. Development of a lavage solution associated with minimal water and electrolyte absorption or secretion. Gastroenterology 1980;78(5 pt 1):991–995.
Goldman J, Reichelderfer M. Evaluation of rapid colonoscopy preparation using a new gut lavage solution. Gastrointest Endosc 1982;28(1):9–11.
DiPalma JA, Brady CE 3rd. Colon cleansing for diagnostic and surgical procedures: polyethylene glycolelectrolyte lavage solution. Am J Gastroenterol 1989;84(9):1008–1016.
Andorsky RI, Goldner F. Colonic lavage solution (polyethylene glycol electrolyte lavage solution) as a treatment for chronic constipation: a double-blind, placebo-controlled study. Am J Gastroenterol 1990;85(3):261–265.
Velio P, Bassotti G. Chronic idiopathic constipation: pathophysiology and treatment. J Clin Gastroenterol 1996;22(3):190–196.
Corazziari E, Badiali D, Habib FI, et al. Small volume isosmotic polyethylene glycol electrolyte balanced solution (PMF-100) in treatment of chronic nonorganic constipation. Dig Dis Sci 1996;41(8):1636–1642.
Hammer HF, Santa Ana CA, Schiller LR, Fordtran JS. Studies of osmotic diarrhea induced in normal subjects by ingestion of polyethylene glycol and lactulose. J Clin Invest 1989;84(4):1056–1062.
DiPalma JA, DeRidder PH, Orlando RC, Kolts BE, Cleveland MB. A randomized, placebo-controlled, multicenter study of the safety and efficacy of a new polyethylene glycol laxative. Am J Gastroenterol 2000;95(2):446–450.
Cleveland MV, Flavin DP, Ruben RA, Epstein RM, Clark GE. New polyethylene glycol laxative for treatment of constipation in adults: a randomized, double-blind, placebo-controlled study. South Med J 2001;94(5):478–481.
Loening-Baucke V. Polyethylene glycol without electrolytes for children with constipation and encopresis. J Pediatr Gastroenterol Nutr 2002;34(4):372–377.
Di Palma JA, Smith JR, Cleveland M. Overnight efficacy of polyethylene glycol laxative. Am J Gastroenterol 2002;97(7):1776–1779.
Kinservik MA, Friedhoff MM. The efficacy and safety of polyethylene glycol 3350 in the treatment of constipation in children. Pediatr Nurs 2004;30(3):232–237.
Rowe VK, Wolf MA. Glycols. In: Clayton GD, Clayton FE eds. Patty’s Industrial Hygiene and Toxicology. New York: John Wiley, 1982:3844–3852.
Shaffer CB, Critchfield FH. The absorption and excretion of the solid polyethylene glycols (carbowax compounds). J Am Pharm Assoc Sci Ed 1947;36:152–157.
Vialli MM, Ersapmer V. Ricerche sul secreto delle cellule enterocromaffini. IX Intorno alla natura chimica della sostanza specifica. Boll Soc Med Chir Pavia 1937;51:1111–1116.
Erspamer V. Occurrence of indolealkyamines in nature. In: Erspamer V, ed. Handbook of Experimental Pharmacology: 5-Hydroxytryptamine and Related Indolealkyamines. New York: Springer-Verlag, 1966:132–181.
Grider JR, Kuemmerle JF, Jin JG. 5-HT released by mucosal stimuli initiate peristalsis by activating 5-HT4/5-HT1p receptors on sensory CGRP neurons. Am J Physiol 1996;270:778–782.
Johanson JF, Wald A, Tougas G, et al. Effect of tegaserod in chronic constipation: a randomized, double-blind, controlled trial. Clin Gastroenterol Hepatol 2004;2:796–805.
De Schepper HU, Cremonini F, Park MI, et al. Opioids and the gut: pharmacology and current clinical experience. Neurogastroenterol Motil 2004;16:383–394.
Kurz A, Sessler DI. Opioid-induced bowel dysfunction: pathophysiology and potential new therapies. Drugs 2003;63:649–671.
Kaufman PN, Krevsky B, Malmud LS, et al. Role of opiate receptors in the regulation of colonic transit. Gastroenterology 1988;94:1351–1356.
Pasternak GW. Pharmacological mechanisms of opioid analgesics. Clin Neuropharmacol 1993;16:1–18.
Gonenne J, Camilleri M, Ferber I, et al. Effect of alvimopan and codeine on gastrointestinal transit: a randomized controlled study. Clin Gastroenterol Hepatol 2005;3:784–791.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer-Verlag London Limited
About this chapter
Cite this chapter
Sandler, R.B., Person, B., Raju, R. (2006). Medical Treatment of Constipation. In: Wexner, S.D., Duthie, G.S. (eds) Constipation. Springer, London. https://doi.org/10.1007/978-1-84628-275-1_14
Download citation
DOI: https://doi.org/10.1007/978-1-84628-275-1_14
Publisher Name: Springer, London
Print ISBN: 978-1-85233-724-7
Online ISBN: 978-1-84628-275-1
eBook Packages: MedicineMedicine (R0)